Cancer vaccines : new research /

Cancer vaccines : new research /

42

Detalhes bibliográficos
Autor principal:	Elliot, Nathan
Formato:
Idioma:	eng
Publicado em:	New York, NY : Nova Science Publisher, 2006
Assuntos:	Cancer vaccines Cancer

Registos relacionados

Cancer vaccines : from research to clinical practice /
Por: Bot, Adrian, editor, et al.
Publicado em: (2011)

Cancer vaccines : methods and protocols /
Por: Lawman, Michael J. P., editor, et al.
Publicado em: (2014)

mRNA cancer vaccines from bench to bedside: a new era in cancer immunotherapy
Por: Alireza Shariati, et al.
Publicado em: (2024-12-01)

Vaccination in children with cancer
Por: D. Y. Kachanov, et al.
Publicado em: (2022-11-01)

Tumor immunology and cancer vaccines /
Por: Khleif, Samir
Publicado em: (2005)

Tumor immunotherapy and cancer vaccines /
Por: Dennis, Eden, editor
Publicado em: (2015)

Cancer vaccines and tumor immunity /
Por: Orentas, Rimas, et al.
Publicado em: (2008)

Tumor immunology : immunotherapy and cancer vaccines /
Por: Dalgleish, A. G. (Angus G.), et al.
Publicado em: (1996)

The Past, Present, and Future of Cervical Cancer Vaccines
Por: Alexander C. Lien, et al.
Publicado em: (2025-02-01)

Advances in nucleic acid-based cancer vaccines
Por: Hung-Chun Liao, et al.
Publicado em: (2025-01-01)

DNA vaccines as promising immuno-therapeutics against cancer: a new insight
Por: Alireza Shariati, et al.
Publicado em: (2025-01-01)

General principles of tumor immunotherapy : basic and clinical applications of tumor immunology /
Por: Kaufman, Howard L., et al.
Publicado em: (2007)

Vaccination Status and Effectiveness of COVID‐19 Vaccines in Patients with Prostate and Bladder Cancer
Por: Ali Nowroozi, et al.
Publicado em: (2024-08-01)

Developing a personalized heterologous prime boost vaccination strategy for tumor therapy
Por: Ramirez-Valdez, RA
Publicado em: (2021)

Mycobacterium spp. exposure, childhood vaccinations, and early childhood brain and CNS cancers
Por: Samer Singh, et al.
Publicado em: (2025-01-01)

Challenges and New Directions in Therapeutic Cancer Vaccine Development
Por: Danjie Pan, et al.
Publicado em: (2024-11-01)

Vaccine Therapies for Prostate Cancer: Current Status and Future Outlook
Por: Wenhao Zhou, et al.
Publicado em: (2024-12-01)

Therapeutic Vaccines for Hematological Cancers: A Scoping Review of This Immunotherapeutic Approach as Alternative to the Treatment of These Malignancies
Por: Fernando Augusto Siqueira Mathias, et al.
Publicado em: (2025-01-01)

Manufacturing and Financial Evaluation of Peptide-Based Neoantigen Cancer Vaccines for Triple-Negative Breast Cancer in the United Kingdom: Opportunities and Challenges
Por: Adriana Novakova, et al.
Publicado em: (2025-01-01)

Potential and development of cellular vesicle vaccines in cancer immunotherapy
Por: Wenxi Zhao, et al.
Publicado em: (2025-01-01)

Safety and efficacy of COVID-19 vaccines in children and adolescents with cancer
Por: Nilgün Kurucu, et al.
Publicado em: (2024-10-01)

Impact of social determinants and medical mistrust on parent-child HPV vaccination in economically disadvantaged communities: implications for cancer prevention
Por: Marcelo M. Sleiman, et al.
Publicado em: (2025-01-01)

Understanding cervical cancer, human papillomavirus (HPV), and HPV vaccine acceptance in college-going students: Institutional-based cross-sectional study from Bihar State
Por: Ekta Krishna, et al.
Publicado em: (2025-01-01)

Anti-Tumor Immunity to Patient-Derived Breast Cancer Cells by Vaccination with Interferon-Alpha-Conditioned Dendritic Cells (IFN-DC)
Por: Caterina Lapenta, et al.
Publicado em: (2024-09-01)

Telomerase-based vaccines: a promising frontier in cancer immunotherapy
Por: Sogand Vahidi, et al.
Publicado em: (2024-12-01)

Knowledge and attitude among Egyptian medical students regarding the role of human papillomavirus vaccine in prevention of oropharyngeal cancer: a questionnaire-based observational study
Por: Mohammed. N. Abdelaziz, et al.
Publicado em: (2025-01-01)

Cancer vaccines: platforms and current progress
Por: Wanting Lei, et al.
Publicado em: (2025-01-01)

COVID-19 Vaccine Hesitancy Among Pediatric Oncology and Bone Marrow Transplant Patients
Por: Sarah A. O’Neill, et al.
Publicado em: (2024-12-01)

The Road Ahead in Pancreatic Cancer: Emerging Trends and Therapeutic Prospects
Por: Chris T. P. Do, et al.
Publicado em: (2024-09-01)

mRNA vaccine platforms: linking infectious disease prevention and cancer immunotherapy
Por: Dariush Haghmorad, et al.
Publicado em: (2025-03-01)

Truncated chicken anemia virus-VP3 as a potential anti tumour vaccine
Por: Lim, Shen Ni
Publicado em: (2012)

Big data analysis of influenza vaccination and liver cancer risk in hypertensive patients: insights from a nationwide population-based cohort study
Por: Chun-Chih Chiu, et al.
Publicado em: (2025-02-01)

Transdermal delivery of PeptiCRAd cancer vaccine using microneedle patches
Por: Carmine D'Amico, et al.
Publicado em: (2025-03-01)

VACCIMEL, an allogeneic melanoma vaccine, efficiently triggers T cell immune responses against neoantigens and alloantigens, as well as against tumor-associated antigens
Por: Ibel Carri, et al.
Publicado em: (2025-01-01)

Personalized cancer vaccine design using AI-powered technologies
Por: Anant Kumar, et al.
Publicado em: (2024-11-01)

Persistent oral HPV infections – Are we vaccinating against the right HPV types to prevent HPV-related oropharyngeal cancer?
Por: Annika Antonsson
Publicado em: (2024-06-01)

Microbiome Differences in Colorectal Cancer Patients and Healthy Individuals: Implications for Vaccine Antigen Discovery
Por: Ibeanu GC, et al.
Publicado em: (2024-12-01)

Seasonal influenza vaccination among cancer patients during the COVID-19 pandemic in Poland
Por: Mikołaj Bartoszkiewicz, et al.
Publicado em: (2021-09-01)

Challenges of COVID-19 vaccination in patients with cancer
Por: Jia Siyue, et al.
Publicado em: (2022-03-01)

Human Papillomavirus-Related Cancer Vaccine Strategies
Por: Xia Cai, et al.
Publicado em: (2024-11-01)